Abstract
Somatostatin (SS) is a representative member of the family of small regulatory peptides which are often characterised by a wide spectrum of actions in various organs of the human body. One of the most prominent and well-documented roles of SS is its inhibition of hormone secretory processes, in particular in the pituitary (GH, TSH) and in the gastroenteropancreatic (GEP) system (Insulin, Glucagon, ViP, Secretin, etc...)1. In addition, SS can modulate the neurotransmission in various brain regions1. All these SS actions seem to be mediated through specific SS receptors (SS-R)2.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Reichlin S.: Somatostatin. N. Engl. J. Med. 309:1495 (1983).
Reubi J.C., Kvols L., Krenning E. and Lamberts S.W.J.: Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 39:78 (1990).
Schally A.V.: Oncological applications of somatostatin analogues. Cancer Res. 48:6977 (1988).
Reubi J.C., Krenning E., Lamberts S.W.J. and Kvols L.: Somatostatin receptors in malignant tissues. J. Steroid Biochem. Molec. Biol. 37(6):1073 (1990).
Reubi J.C., Waser B., van Hagen M., Lamberts S.W.J., Krenning E.P., Gebbers J.O. and Laissue J.: In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int. J. Cancer. 50:895 (1992)
Reubi J.C., Waser B., Foekens J., Klijn J., Lamberts S.W.J. and Laissue J.: Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int. J. Cancer 46:416 (1990).
Papotti M., Macri L., Bussolati G. and Reubi J.C.: Correlative study on neuroendocrine differentiation and presence of somatostatin receptors in breast carcinomas. Int. J. Cancer 43:365 (1989).
Reubi J.C., Kvols L.K., Waser B., Nagorney D.M., Heitz P.U., Charboneau J.W., Reading C.C. and Moertel C.: Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res. 50:5969 (1990).
Reubi J.C., Chayvialle J.A., Franc B., Cohen R., Calmettes C. and Modigliani E.: Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab. Invest. 64:567 (1991).
Reubi J.C., Waser B., Sheppard M. and Macaulay V.: Somatostatin receptors are present in small cell but not in non-small cell primary lung carcinomas: relationship to EGF-receptors. Int. J. Cancer 45:269 (1990).
Reubi J.C., Horisberger U., Lang W., Koper J.W., Braakman R. and Lamberts S.W.J.: Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am. J. Path. 134:337 (1988).
Reubi J.C.: Evidence for two somatostatin-14 receptor types in rat brain cortex. Neurosci. Lett. 49:259 (1984).
Reubi J.C., Probst A., Cortes R. and Palacios J.M.: Distinct topographical localisation of two somatostatin receptor subpopulations in the human cortex. Brain Res. 406:391 (1987).
Markstein R., Stoeckli K.A. and Reubi J.C.: Differential effects of somatostatin on adenylate cyclase as functional correlates for different brain somatostatin receptor subpopulations. Neurosci. Lett. 104:13 (1989).
Reubi J.C., Haecki W.H. and Lamberts S.W.J.: Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J. Clin. Endocr. Metab. 65:1127 (1987).
Lamberts S.W.J., Hof land L.J., Koetsveld P. van, Reubi J.C., Bruining H.A., Bakker W.H. and Krenning E.P.: Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors. Consequences with regard to diagnosis, localisation and therapy. J. Clin. Endocr. Metab. 71:566 (1990).
Reubi J.C., Horisberger U., Klijn J.G.M. and Foekens J.A.: Somatostatin receptors in differentiated ovarian tumors. Amer. J. Pathol. 138:1267 (1991).
Srkalovic G., Cai R.-Z. and Schally A.V.: Evaluation of receptors for somatostatin in various tumors using different analogs. J. Clin. Endocr. Metab. 70:661 (1990).
Reubi J.C. and Landolt A.M.: The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. J. Clin. Endocr. Metab. 68:844 (1989).
Levy A., Eckland D.J.A., Gurney A.M., Reubi J.C., Doshi R. and Lightman S.L.: Somatostatin and thyrotrophinreleasing hormone response and receptor status of a thyrotrophin secreting pituitary adenoma: clinical and in vitro studies. J. Neuroendocr. 1:321 (1989).
Evers B.M., Townsend C.M., Upp J.R., Allen E., Hurlbut S.C., Kim S.W., Rajaraman R., Singh P., Reubi J.C. and Thompson J.C.: Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 101:303 (1991).
Lamberts S.W.J., Krenning E.P. and Reubi J.C.: The role of somatostatin and its analogs in the diagnosis and treatment of cancer. Endocr. Rev. 12:450 (1991).
Taylor J.E., Bogden A.E., Moreau J.-P. and Coy D.H.: In vitro and in vivo inhibition of human small-cell lung carcinoma (NCI-H69) growth by a somatostatin analogue. Biochem. Biophys. Res. Commun. 153:81 (1988).
Bakker G.H., Setyono-Han B., Foekens J.A., Portengen H., van Putten W.L.J., de Jong F.H., Lamberts S.W.J., Reubi J.C. and Klijn J.G.M.: Treatment of rats bearing DMBAinduced mammary tumors with the Sandostatin analog (SMS 201–995). Breast Cancer Res. Treat. 17:23 (1990).
Reubi J.C.: A somatostatin analog inhibits chondrosarcoma and insulinoma tumor growth. Acta Endocrin. 109:108 (1985).
Koper J.W., Markstein R., Kohler C., Kwekkeboom D.J., Avezaat C.J.J., Lamberts S.W.J. and Reubi J.C.: Somatostatin inhibits activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J. Clin. Endocr. Metab. 74:543 (1991).
Krenning E.P., Bakker W.H., Breeman W.A.P., Koper J.W., Kooij P.P.M., Ausema L., Lameris J.S., Reubi J.C. and Lamberts S.W.J.: Localization of endocrine-related tumours with radio-iodinated analogue of somatostatin. Lancet i:242 (1989).
Lamberts S.W.J., Bakker W.H., Reubi J.C. and Krenning E.P.: The value of somatostatin receptor imaging in the localization of endocrine and brain tumors. New Engl. J. Med. 323:1246 (1990).
Krenning E.P., Bakker W.H., Kooij P.P.M., Breeman W.A.P., Oei H.Y., de Jong M., Reubi J.C., Visser T.J., Bruns C., Kwekkeboom D.J., Reijs A.E.M., van Hagen P.M., Koper J.W. and Lamberts S.W.J.: Somatostatin receptor scintigraphy with [111-In-DTPA-D-Phe-1]-octreotide. J. Nucl. Med. 33:652 (1992).
Foekens J.A., Portengen H., Putten W.L.J. van, MacTrapman A., Reubi J.C., Alexieva-Figush J. and Klijn J.G.M.: Prognostic value of receptors for insulin-like growth factor-I, somatostatin and epidermal growth factor in human breast cancer. Cancer Res. 49:7002 (1989).
Moertel C.L., Reubi J.C., Scheithauer B., Schaid D.J. and Kvols L.K.: Somatostatin receptors (SS-R) are expressed and correlate with prognosis in childhood neuroblastoma. Proc. Am. Soc. Ped. Res.: Abstr. 306 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Plenum Press, New York
About this chapter
Cite this chapter
Reubi, J.C., Krenning, E., Lambert, S.W. (1993). The Role of Somatostatin Receptors in the Diagnosis and Therapy of Cancer. In: Moody, T.W. (eds) Growth Factors, Peptides and Receptors. GWUMC Department of Biochemistry and Molecular Biology Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2846-3_43
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2846-3_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44484-5
Online ISBN: 978-1-4615-2846-3
eBook Packages: Springer Book Archive